New Type 2 Diabetes And Obesity Treatment Approved – EndoBarrier Receives European CE Mark
October 31st, 2009
New Type 2 Diabetes And Obesity Treatment Approved – EndoBarrier Receives European CE Mark
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French “Conformite Europeenne”) certifies that a product has met EU requirements for marketing in Europe. Clinical trials …
Read more on Medical News Today
